PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 12, 2026Alcohol Clinical and Experimental Research0 citationsOpen Access

Participant Demographic and Baseline Drinking Factors Can Predict Alcohol Use Disorder Pharmacotherapy Clinical Trial Completion and Drinking Outcomes

View Full Paper
MHMichaela HoffmanRARaymond F. AntonAAArnie Aldridge

Key Points

  • The aim is to identify baseline drinking factors that may influence the completion of alcohol pharmacotherapy trials and drinking outcomes.
  • Analyzed demographic and baseline drinking characteristics of participants in pharmacotherapy trials.
  • Identified risk categories related to drinking habits.
  • Older participants and those with less abstinence showed different trial completion rates.
  • Higher risk drinking categories were linked to less favorable drinking outcomes.

Abstract

These findings suggest that some important prestudy drinking characteristics (e.g., less abstinence and older age) as well as being in a higher risk drinking category should be considered for inclusion in future alcohol pharmacotherapy trials.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hoffman et al. (2026) studied this question.

synapsesocial.com/papers/69db38534fe01fead37c690chttps://doi.org/10.1111/acer.70288
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Reductions in World Health Organization Risk Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials2025 · 27 citations
  2. 2A Double‐Blind, Placebo‐Controlled Trial to Assess the Efficacy of Quetiapine Fumarate XR in Very Heavy‐Drinking Alcohol‐Dependent Patients2011 · 94 citations
  3. 3Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence2006 · 1,936 citations
  4. 4Index for rating diagnostic tests1950 · 11,746 citations
  5. 5A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence2013 · 290 citations